{"cdcTestId":"2018-0011","testcaseName":"Zoster: Dose #1 of Shingrix 8 weeks after Dose #2 of Varicella vaccine","vaccineGroup":"ZOSTER","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on minimum interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1972-09-24T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2019-08-24T00:00:00","vaccineName":"VARIVAX","cvx":"21","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"varicella","cvx":"21","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"SHINGRIX","cvx":"187","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"2023-06-15T00:00:00"},"doses":[{"dateAdministered":"2019-08-24T00:00:00","vaccineName":"VARIVAX","cvx":"21","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"varicella","cvx":"21","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"SHINGRIX","cvx":"187","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2018-04-11T20:00:00","dateUpdated":"2022-09-27T08:46:41.888","generalDescription":"This test case describes when a patient is administered a dose of Zoster (Shingrix) vaccine 8 weeks after the second dose of Varicella vaccine, that the doses are considered to be valid.","changedInVersion":"4.27","reasonForChange":"v 4.27 Updated Forecast minimum interval from 8 weeks to 4 weeks, to align with ACIP recommendations."}